Velocity Clinical Research, UK

Velocity Clinical Research, UK Egin Research is a network of dedicated clinical research centres.

We want to take a moment to recognize an achievement that exemplifies what Velocity at Scale is all about. Kirsten Peace...
04/06/2026

We want to take a moment to recognize an achievement that exemplifies what Velocity at Scale is all about.

Kirsten Peacey, MBBS and her team at our Bristol, UK site have reached a major Phase 3 trial milestone — completing End of Screening 4.5 months ahead of the original projected timeline.

That's not luck. It's what happens when an experienced, protocol-ready team operates within a purpose-built research network.

Dr. Peacey's site was the top-performing UK site on this study — leading on randomizations, maintaining strong screen failure rates, and upholding the highest standards of patient safety and data quality throughout.

This is precisely why Velocity invests in building sites that are consistently ready to perform:
• Faster activation — dedicated infrastructure means our sites are trial-ready from day one, not months later
• Reduced risk — experienced teams with proven protocols deliver consistent, high-quality results sponsors can rely on
• Velocity at Scale — when operational excellence is shared across our network, every site benefits — and so do our sponsors

To Dr. Peacey and the entire Bristol team: thank you. Your dedication brought a potential new therapy closer to the patients who need it — ahead of schedule and without compromise.

At Velocity Clinical Research, we recognize the diversity and strength of the Hispanic and Latinx communities that enric...
15/09/2024

At Velocity Clinical Research, we recognize the diversity and strength of the Hispanic and Latinx communities that enrich our nation. Join us in celebrating the beauty of Hispanic heritage, the resilience of its people, and the impact they've made and continue to make every day, especially in clinical research.

Respiratory infections, including the flu, COVID-19, and the common cold, tend to present similar symptoms, which can ma...
12/09/2024

Respiratory infections, including the flu, COVID-19, and the common cold, tend to present similar symptoms, which can make them difficult to diagnose or identify. In this article, you’ll learn about viral, fungal, and bacterial respiratory infections, their similarities, differences, and current treatment options.

Respiratory infections tend to present similar symptoms which can make them difficult to diagnose or identify.

The future of clinical trials, now available in the palm of your hand. Meet VISION Engage!This app empowers you to easil...
07/09/2024

The future of clinical trials, now available in the palm of your hand. Meet VISION Engage!

This app empowers you to easily match with new study opportunities, earn rewards, and turn connections into cash. Don’t wait! Download the app today at http://velocityclinicaltrials.com/vision-engage-app

Judy, a Velocity COVID-19 vaccine trial participant, describes participating in research studies as “interesting and rew...
29/08/2024

Judy, a Velocity COVID-19 vaccine trial participant, describes participating in research studies as “interesting and rewarding.” She recommends others join a clinical trial, too. Read more of her perspective on being involved in clinical research in our blog post:

What led you to participate in a research study? I heard about it on Facebook. The money intrigued me, but then the chance to help

Meet VISION Engage! Download the official Velocity app to get matched with new studies, earn rewards, and help move scie...
24/08/2024

Meet VISION Engage! Download the official Velocity app to get matched with new studies, earn rewards, and help move science forward. Download the app and view terms:
https://buff.ly/49bJvIm

Atopic Dermatitis (AD), better known as eczema, is a common skin condition causing red, itchy, dry patches of skin to co...
13/08/2024

Atopic Dermatitis (AD), better known as eczema, is a common skin condition causing red, itchy, dry patches of skin to come and go periodically. In the U.S. alone, an estimated 31.6 million people (more than 10% of the population) have eczema. While there are multiple treatments available for AD, experts hope that there are better treatments still to be found. Read more about eczema and clinical trials studying it in our Learning Center article:

Read about the first monoclonal antibody (MAB) treatment to be approved for use against atopic dermatitis and eczema research initiatives

Curious about how the flu vaccine has evolved over the years? Discover the fascinating journey from its early developmen...
07/08/2024

Curious about how the flu vaccine has evolved over the years? Discover the fascinating journey from its early development to modern advances in our latest blog post!

Discover the history and evolution of the flu vaccine, a key tool in public health.

Thanks to science, vaccines have helped us fight many potentially fatal or debilitating diseases. This  , we encourage e...
01/08/2024

Thanks to science, vaccines have helped us fight many potentially fatal or debilitating diseases. This , we encourage everyone to learn more about the vaccines available to them, and to consider joining a clinical trial to support the next generation of live-saving vaccines. Learn more at https://buff.ly/3rStkPP.

Address

Apollo Centre, Desborough Road
High Wycombe
HP112QW

Opening Hours

Monday 9am - 8pm
Tuesday 9am - 8pm
Wednesday 9am - 8pm
Thursday 9am - 8pm
Sunday 9am - 8pm

Alerts

Be the first to know and let us send you an email when Velocity Clinical Research, UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share